drugset / Trial / NCT06270511

A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants

NCT06270511 ↗

Phase 1 Completed 50 enrolled Shionogi
RandomizedCrossoverOpen-labelBasic science

Summary

The aim of this study is to investigate different formulations of S-337395.

Timeline

Start
2024-03-13
Primary completion
2024-05-30
Completion
2024-06-19

Drugs

EvaluationDrugModalityDoseRoute
Subject S-337395 Unknown — Oral

Indications

No indication recorded.